Australia’s medicine regulator has identified a second case of rare blood clots believed to be linked to the AstraZeneca vaccine.
The Therapeutic Goods Administration released a safety alert announcing the possible link on Tuesday.
The blood clots affected a woman aged in her 40s who was vaccinated in Western Australia.
“The person remains in hospital receiving treatment and is in a stable condition,” the regulator said.
The rare but potentially deadly blood-clotting disorder recently resulted in the AstraZeneca vaccine being no longer recommended to any Australians aged under 50, derailing the national vaccine rollout.
It is the second Australian report of a case of rare blood clots after a 44-year-old Melbourne man developed the condition…